ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Thomas, Colleen J ^a   May, Clive N ^a   Sharma, Atul D ^a   Woods, Robyn L ^a  

^a NONE

Author keywords

Atrial natriuretic factor; Cardiogenic chemoreflexes; Heart period; Heart rate

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PHENYLBIGUANIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR REFLEX; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; HEART CYCLE; HEART RATE; JUGULAR VEIN; NONHUMAN; PRIORITY JOURNAL; SHEEP; VAGUS REFLEX;

EID: 0035019383     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.1.r282     Document Type: Article

References (37)

1. Ackermann U, Irizawa TG, Milojevic S, and Sonnenberg H. Cardiovascular effects of atrial extracts in anesthetized rats. Can J Physiol Pharmacol 62: 819-826, 1984.
2. Aviado DMJ, Pontius RG, and Schmidt CF. The reflex respiratory and circulatory actions of veratridine on pulmonary, cardiac and carotid receptors. J Pharm Pharmacol 97: 420-431, 1949.
3. Barron KW and Bishop VS. Reflex cardiovascular changes with veratridine in the conscious dog. Am J Physiol Heart Circ Physiol 242: H810-H817, 1982.
4. Charles CJ, Espiner EA, Richards AM, Nicholls MG, and Yandle TG. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Am J Physiol Regulatory Integrative Comp Physiol 270: R1324-R1331, 1996.
5. Chen HH and Burnett JC Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32, Suppl 3: S22-S28, 1998.
6. Dawes GS, Mott JC, and Widdicombe JG. Respiratory and cardiovacular reflexes from the heart and lungs. J Physiol (Lond) 115: 258-291, 1951.
7. De Bold AJ, Bruneau BG, and Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 31: 7-18, 1996.
8. Deliva RD and Ackermann U. Atrial natriuretic peptide and mechanisms of cardiovascular control. Role of serotonergic receptors. Am J Physiol Regulatory Integrative Comp Physiol 274: R711-R717, 1998.
9. Espiner EA, Richards AM, Yandle TG, and Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 24: 481-509, 1995.
10. Faris IB, Iannos J, Jamieson GG, and Ludbrook J. Comparison of methods for eliciting the baroreceptor-heart rate reflex in conscious rabbits. Clin Exp Pharmacol Physiol 7: 281-291, 1980.
11. Hainsworth R. Reflexes from the heart. Physiol Rev 71: 617-658, 1991.
12. Kato H, Yasue H, Yoshimura M, Tanaka H, Miyao Y, Okumura K, Ogawa H, and Nakao K. Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina. Am Heart J 128: 1098-1104, 1994.
13. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, Kugiyama K, Ogawa H, Okumura K, Ogawa Y, and Nakao K. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 132: 101-107, 1996.
14. Kyriakides ZS, Markianos M, Michails L, Antoniadis A, Nikolaou NI, and Kremastinos DT. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 23: 285-288, 2000.
15. Lin X, Hanze J, Heese F, Sodmann R, and Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 77: 750-758, 1995.
16. Ludbrook J. Cardiovascular reflexes from cardiac sensory receptors. Aust NZ J Med 20: 597-606, 1990.
17. Ludbrook J and Evans RG. Cardiac chemoreceptors: pharmacological curiosities or physiological tools? Clin Exp Pharmacol Physiol 18: 101-105, 1991.
18. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1: 90-102, 1983.
19. Nicholls MG. The natriuretic peptides in heart failure. J Intern Med 235: 515-526, 1994.
20. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, and Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 67: 482-485, 1992.
21. Ogawa Y, Itoh H, and Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol 22: 49-53, 1995.
22. Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, and Richards AM. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure. Clin Sci (Colch) 92: 159-165, 1997.
23. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Colch) 95: 519-529, 1998.
24. Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, and Coleridge JC. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol Regulatory Integrative Comp Physiol 255: R6-R13, 1988.
25. Schultz HD and Ustinova EE. Cardiac vagal afferent stimulation by free radicals during ischaemia and reperfusion. Clin Exp Pharmacol Physiol 23: 700-708, 1996.
26. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, and Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239, 1992.
27. Thames M, Dibner-Dunlop M, and Minis A. Cardiovascular reflexes during myocardial ischaemia and infarction. In: Cardiovascular Reflex Control in Health and Disease, edited by Mark R and Hainsworth R. London, UK: Saunders, 1993, p. 235-255.
28. Thomas CJ, Head GA, and Woods RL. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy. Hypertension 32: 548-555, 1998.
29. Thomas CJ, Head GA, and Woods RL. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats. J Hypertens 17: 801-806, 1999.
30. Thomas CJ, Rankin AJ, Head GA, and Woods RL. ANP enhances bradycardic reflexes in normotensive but not sponta-neously hypertensive rats. Hypertension 29: 1126-1132, 1997.
31. Thoren P, Mark AL, Morgan DA, O'Neill TP, Needleman P, and Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 251: H1252-H1259, 1986.
32. Vesalainen RK, Kantola IM, Airaksinen KE, Tahvanainen KU, and Kaila TJ. Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril. Am J Hypertens 11: 649-658, 1998.
33. Wei CM, Aarhus LL, Miller VM, and Burnett JC Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol Heart Circ Physiol 264: H71-H73, 1993.
34. Wennberg PW, Miller VM, Rabelink T, and Burnett JC Jr. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism. Am J Physiol Heart Circ Physiol 277: H1618-H1621, 1999.
35. Woods RL, Courneya CA, and Head GA. Nonuniform enhancement of baroreflex sensitivity by atrial natriuretic peptide in conscious rats and dogs. Am J Physiol Regulatory Integrative Comp Physiol 267: R678-R686, 1994.
36. Woods RL and Jones MJ. Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs. Am J Physiol Regulatory Integrative Comp Physiol 276: R1443-R1452, 1999.
37. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide compared with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203, 1994.